In silico investigation of the effect of particle diameter on deposition uniformity in pulmonary drug delivery

References

• Alatrash, A., R. Mehri, N. Ogrodnik, E. Matida, and F. Fiorenza. 2019. Experimental study of Spiriva Respimat soft mist inhaler spray characterization: Size distributions and velocity. J. Aerosol Med. Pulm. Drug Deliv. 32 (5):293–302. doi:10.1089/jamp.2018.1501.
   PubMed Web of Science ®Google Scholar
• Anjilvel, S., and B. Asgharian. 1995. A multiple-path model of particle deposition in the rat lung. Fundam. Appl. Toxicol. 28 (1):41–50. doi:10.1006/faat.1995.1144.
   PubMedGoogle Scholar
• Anselmo, A. C., Y. Gokarn, and S. Mitragotri. 2019. Non-invasive delivery strategies for biologics. Nat. Rev. Drug Discov. 18 (1):19–40. doi:10.1038/nrd.2018.183.
   PubMed Web of Science ®Google Scholar
• Asgharian, B., W. Hofmann, and R. Bergmann. 2001. Particle deposition in a multiple-path model of the human lung. Aerosol Sci. Technol. 34 (4):332–9. doi:10.1080/02786820119122.
   Web of Science ®Google Scholar
• Beeckmans, J. M. 1965. The deposition of aerosols in the respiratory tract: I. Mathematical analysis and comparison with experimental data. Can. J. Physiol. Pharmacol. 43 (1):157–72. doi:10.1139/y65-015.
   PubMed Web of Science ®Google Scholar
• Benque, B., and J. G. Khinast. 2021. Estimating inter-patient variability of dispersion in dry powder inhalers using CFD-DEM simulations. Eur. J. Pharm. Sci. 156:105574. doi:10.1016/j.ejps.2020.105574.
   PubMed Web of Science ®Google Scholar
• Borghardt, J. M., B. Weber, A. Staab, and C. Kloft. 2015. Pharmacometric models for characterizing the pharmacokinetics of orally inhaled drugs. AAPS J. 17 (4):853–70. doi:10.1208/s12248-015-9760-6.
   PubMed Web of Science ®Google Scholar
• Borgstrom, L., E. Bondesson, F. Moren, E. Trofast, and S. P. Newman. 1994. Lung deposition of budesonide inhaled via Turbuhaler: A comparison with terbutaline sulphate in normal subjects. Eur. Respir. J. 7 (1):69–73. doi:10.1183/09031936.94.07010069.
   PubMed Web of Science ®Google Scholar
• Brand, P., I. Friemel, T. Meyer, H. Schulz, J. Heyder, and K. Häuβinger. 2000. Total deposition of therapeutic particles during spontaneous and controlled inhalations. J. Pharm. Sci. 89 (6):724–31. doi:10.1002/(SICI)1520-6017(200006)89:6%3C724::AID-JPS3%3E3.0.CO;2-B.
   PubMed Web of Science ®Google Scholar
• Brand, P., B. Hederer, G. Austen, H. Dewberry, and T. Meyer. 2008. Higher lung deposition with Respimat® Soft MistTM Inhaler than HFA-MDI in COPD patients with poor technique. Int. J. Chronic Obstruct. Pulm. Dis. 3 (4):763. doi:10.2147/COPD.S3930.
   PubMedGoogle Scholar
• Brand, P., C. Rieger, H. Schulz, T. Beinert, and J. Heyder. 1997. Aerosol bolus dispersion in healthy subjects. Eur. Respir. J. 10 (2):460–7. doi:10.1183/09031936.97.10020460.
   PubMed Web of Science ®Google Scholar
• Chen, X., Y. Feng, W. Zhong, B. Sun, and F. Tao. 2018. Numerical investigation of particle deposition in a triple bifurcation airway due to gravitational sedimentation and inertial impaction. Powder Technol. 323:284–93. doi:10.1016/j.powtec.2017.09.050.
   Web of Science ®Google Scholar
• Cheng, Y. S., Y. Zhou, and W. C. Su. 2015. Deposition of particles in human mouth–throat replicas and a USP induction port. J. Aerosol Med. Pulm. Drug Deliv. 28 (3):147–55. doi:10.1089/jamp.2013.1105.
   PubMed Web of Science ®Google Scholar
• Darquenne, C. 2020. Deposition mechanisms. J. Aerosol Med. Pulm. Drug Deliv. 33 (4):181–5. doi:10.1016/j.jaerosci.2019.04.015.
   PubMed Web of Science ®Google Scholar
• Darquenne, C., J. S. Fleming, I. Katz, A. R. Martin, J. Schroeter, O. S. Usmani, J. Venegas, and O. Schmid. 2016. Bridging the gap between science and clinical efficacy: Physiology, imaging, and modeling of aerosols in the lung. J. Aerosol Med. Pulm. Drug Deliv. 29 (2):107–26. doi:10.1089/jamp.2015.1270.
   PubMed Web of Science ®Google Scholar
• Darquenne, C., L. Harrington, and G. K. Prisk. 2009. Alveolar duct expansion greatly enhances aerosol deposition: A three-dimensional computational fluid dynamics study. Philos. Trans. A Math. Phys. Eng. Sci. 367 (1896):2333–46. doi:10.1098/rsta.2008.0295.
   PubMed Web of Science ®Google Scholar
• DeCarlo, P. F., J. G. Slowik, D. R. Worsnop, P. Davidovits, and J. L. Jimenez. 2004. Particle morphology and density characterization by combined mobility and aerodynamic diameter measurements. Part 1: Theory. Aerosol Sci. Technol. 38 (12):1185–205. doi:10.1080/027868290903907.
   Web of Science ®Google Scholar
• Duddu, S. P., S. A. Sisk, Y. H. Walter, T. E. Tarara, K. R. Trimble, A. R. Clark, M. A. Eldon, R. C. Elton, M. Pickford, and P. H. Hirst. 2002. Improved lung delivery from a passive dry powder inhaler using an engineered PulmoSphere® powder. Pharm. Res. 19 (5):689–95. doi:10.1023/A:1015322616613.
   PubMed Web of Science ®Google Scholar
• Foord, N., A. Black, and M. Walsh. 1978. Regional deposition of 2.5–7.5 μm diameter inhaled particles in healthy male non-smokers. J. Aerosol Sci. 9 (4):343–57. doi:10.1016/0021-8502(78)90037-X.
   Google Scholar
• Golshahi, L., M. L. Noga, R. Vehring, and W. H. Finlay. 2013. An in vitro study on the deposition of micrometer-sized particles in the extrathoracic airways of adults during tidal oral breathing. Ann. Biomed. Eng. 41 (5):979–89. doi:10.1007/s10439-013-0747-0.
   PubMed Web of Science ®Google Scholar
• Häussermann, S., K. Sommerer, and G. Scheuch. 2020. Regional lung deposition: In vivo Data. J. Aerosol Med. Pulm. Drug Deliv. 33 (6):291–9. doi:10.1089/jamp.2020.29032.sh.
   PubMed Web of Science ®Google Scholar
• Heyder, J., J. Gebhart, G. Rudolf, C. F. Schiller, and W. Stahlhofen. 1986. Deposition of particles in the human respiratory tract in the size range 0.005–15 μm. J. Aerosol Sci. 17 (5):811–25. doi:10.1016/0021-8502(86)90035-2.
   Web of Science ®Google Scholar
• Hofmann, W., E. Pawlak, and R. Sturm. 2008. Semi-empirical stochastic model of aerosol bolus dispersion in the human lung. Inhal. Toxicol. 20 (12):1059–73. doi:10.1080/08958370802115081.
   PubMed Web of Science ®Google Scholar
• ICRP. 1994. Human respiratory tract model for radiological protection. In ICRP Publication (Vol. 66). Ann. ICRP 24 (1–3), Ottawa, Ontario.
   Google Scholar
• Ingham, D. B. 1975. Diffusion of aerosols from a stream flowing through a cylindrical tube. J. Aerosol Sci. 6 (2):125–32. doi:10.1016/0021-8502(75)90005-1.
   Google Scholar
• Inthavong, K., L.-T. Choi, J. Tu, S. Ding, and F. Thien. 2010. Micron particle deposition in a tracheobronchial airway model under different breathing conditions. Med. Eng. Phys. 32 (10):1198–212. doi:10.1016/j.medengphy.2010.08.012.
   PubMed Web of Science ®Google Scholar
• Kim, Y. H., Z. B. Tong, H. K. Chan, and R. Y. Yang. 2019. CFD modelling of air and particle flows in different airway models. J. Aerosol Sci. 134:14–28.
   Web of Science ®Google Scholar
• Klonoff, D. C. 2014. Afrezza inhaled insulin: The fastest-acting FDA-approved insulin on the market has favorable properties. J. Diabetes Sci. Technol. 8 (6):1071–3. doi:10.1177/1932296814555820.
   PubMedGoogle Scholar
• Kolanjiyil, A. V., C. Kleinstreuer, and R. T. Sadikot. 2017. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application. Comput. Biol. Med. 84:247–53. doi:10.1016/j.compbiomed.2016.10.025.
   PubMed Web of Science ®Google Scholar
• Koullapis, P. G., S. C. Kassinos, M. P. Bivolarova, and A. K. Melikov. 2016. Particle deposition in a realistic geometry of the human conducting airways: Effects of inlet velocity profile, inhalation flowrate and electrostatic charge. J. Biomech. 49 (11):2201–12. doi:10.1016/j.jbiomech.2015.11.029.
   PubMed Web of Science ®Google Scholar
• Landahl, H. D. 1950. On the removal of air-borne droplets by the human respiratory tract: I. The lung. The Bulletin of Mathematical Biophysics 12 (1):43–56. doi:10.1007/BF02477345.
   Google Scholar
• Longest, P. W., and J. Xi. 2007. Computational investigation of particle inertia effects on submicron aerosol deposition in the respiratory tract. J. Aerosol Sci. 38 (1):111–30. doi:10.1016/j.jaerosci.2006.09.007.
   Web of Science ®Google Scholar
• Lu, D., S. L. Lee, R. A. Lionberger, S. Choi, W. Adams, H. N. Caramenico, B. A. Chowdhury, D. P. Conner, R. Katial, S. Limb, et al. 2015. International guidelines for bioequivalence of locally acting orally inhaled drug products: Similarities and differences. AAPS J. 17 (3):546–57. doi:10.1208/s12248-015-9733-9.
   PubMed Web of Science ®Google Scholar
• Mathews, P. G. 2005. Design of experiments with MINITAB (Vol. 446). Milwaukee, WI: ASQ Quality Press.
   Google Scholar
• Montesantos, S., I. Katz, J. Fleming, C. Majoral, M. Pichelin, C. Dubau, B. Piednoir, J. Conway, J. Texereau, and G. Caillibotte. 2013. Airway morphology from high resolution computed tomography in healthy subjects and patients with moderate persistent asthma. Anat. Rec. (Hoboken) 296 (6):852–66. doi:10.1002/ar.22695.
   PubMedGoogle Scholar
• Montesantos, S., I. Katz, M. Pichelin, and G. Caillibotte. 2016. The creation and statistical evaluation of a deterministic model of the human bronchial tree from HRCT images. PLoS One. 11 (12):18–21. doi:10.1371/journal.pone.0168026.
   Web of Science ®Google Scholar
• Montgomery, D. C. 2017. Design and analysis of experiments. Hoboken, NJ: John Wiley & Sons.
   Google Scholar
• Newman, S. P. 2017. Drug delivery to the lungs: Challenges and opportunities. Ther. Deliv. 8 (8):647–61. doi:10.4155/tde-2017-0037.
   PubMed Web of Science ®Google Scholar
• Newman, S. P., G. R. Pitcairn, P. H. Hirst, R. E. Bacon, E. O'Keefe, M. Reiners, and R. Hermann. 2000. Scintigraphic comparison of budesonide deposition from two dry powder inhalers. Eur. Respir. J. 16 (1):178–83. doi:10.1034/j.1399-3003.2000.16a29.x.
   PubMed Web of Science ®Google Scholar
• Olsson, B., E. Bondesson, L. Borgström, S. Edsbäcker, S. Eirefelt, K. Ekelund, L. Gustavsson, and T. Hegelund-Myrbäck. 2011. Pulmonary drug metabolism, clearance, and absorption. Controlled pulmonary drug delivery, 21–50. New York: Springer. doi:10.1007/978-1-4419-9745-6.
   Google Scholar
• Ou, C., H. Jian, and Q. Deng. 2020. Particle deposition in human lung airways: Effects of airflow, particle size, and mechanisms. Aerosol Air Qual. Res. 20:2846–58. doi:10.4209/aaqr.2020.02.0067.
   Web of Science ®Google Scholar
• Patton, J. S., C. S. Fishburn, and J. G. Weers. 2004. The lungs as a portal of entry for systemic drug delivery. Proc. Am. Thorac. Soc. 1 (4):338–44. doi:10.1513/pats.200409-049TA.
   PubMedGoogle Scholar
• Raabe, O. G., H. Yeh, G. M. Schum, and R. F. Phalen. 1976. Tracheobronchial geometry: Human, dog, rat, hamster – A compilation of selected data from the project respiratory tract deposition models. Report LF-53, Lovelace Foundation, Albuquerque, NM.
   Google Scholar
• Sakagami, M. 2020. In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs. Adv. Drug Deliv. Rev. 161:63–74. doi:10.1016/j.addr.2020.07.025.
   PubMed Web of Science ®Google Scholar
• Usmani, O. S., M. F. Biddiscombe, and P. J. Barnes. 2005. Regional lung deposition and bronchodilator response as a function of β2-agonist particle size. Am. J. Respir. Crit. Care Med. 172 (12):1497–504. doi:10.1164/rccm.200410-1414OC.
   PubMed Web of Science ®Google Scholar
• Yu, C. P. 1978. Exact analysis of aerosol deposition during steady breathing. Powder Technol. 21 (1):55–62. doi:10.1016/0032-5910(78)80107-7.
   Web of Science ®Google Scholar